News

Company Announcements

AFR Higher Education Award Research Commercialisation

AFR Higher Education Award Research Commercialisation

Nov 13, 2020

by

Bioshares Interview: Malcolm McColl, CEO ImmVirX

July 13, 2021

Bioshares Interview: Malcolm McColl, CEO ImmVirX

Nov 13, 2020

by

Viralytics band gets back together for ImmVirX cancer start-up

May 13, 2021

Viralytics band gets back together for ImmVirX cancer start-up

Nov 13, 2020

by

$500m Cancer team reassembled

March 9, 2021

$500m Cancer team reassembled

Nov 13, 2020

by

New biotech venture going viral in battle against cancer

January 22, 2020

New biotech venture going viral in battle against cancer

Nov 13, 2020

by

ImmVirX featured in a recent ABC coverage of the Australian Biotech sector

February 12, 2020

ImmVirX featured in a recent ABC coverage of the Australian Biotech sector

Nov 13, 2020

by

The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies

January 22, 2020

The Newcastle Herald features Immvirx on its work to develop cutting-edge cancer therapies

Nov 13, 2020

by

Join Our Mailing List

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect